AKR1C3 and pulmonary arterial hypertension: Taken together, we identified a PAH-specific non-canonical AHR signaling pathway responsible for the induction of AKR1C3 and the associated 11-ketoreduction of PGD2 that provides a plausible link between PAH exposure and the pathogenesis of allergic inflammatory diseases.